WMJ Vol 120 Issue 3: Quality of Dietary Intake in Children With Developmental Disabilities: A Pilot Study
Background: Children with developmental disabilities have a high prevalence of overweight and obesity. The role and contribution of their diet to weight status is poorly understood.
Objectives: This pilot study describes the dietary quality of children with spina bifida and Down syndrome compared with typically developing peers.
Methods: Dietary intakes of 8 children with spina bifida or Down syndrome and 4 children without developmental disabilities, aged 8 to 18 years, were collected using six 24-hour dietary recalls through Facetime. Dietary quality was assessed by application of the Healthy Eating Index (HEI).
Results: Children with spina bifida and Down syndrome had higher HEI scores when compared to typically developing peers (48.3, 52.9, and 46.2, respectively) and vegetable consumption (1.9, 2.6, and 1.4, respectively). All groups had undesirable intakes of saturated fat, added sugar, and sodium. Within this small sample, children with spina bifida and Down Syndrome had similar diet quality to their typically developing peers.
Conclusions: Further investigation in a larger sample is recommended to support the development of methods to optimize weight management in children with developmental disabilities.
The target audience for this journal-based activity is healthcare providers caring for the people and communities of Wisconsin and beyond.
As a result of this journal-based activity, learners will be able to:
- Summarize the known factors associated with weight status in children with spina bifida or Down syndrome.
- Explain the results of the pilot study that used Healthy Eating Index (HEI) to assess quality of dietary intake in children with spina bifida or Down syndrome, in comparison with typically developing children.
- Discuss how improved understanding of the nutritional quality among children and adolescents with developmental disabilities may be used to develop collaborative, team-based interventions aimed at optimizing weight management in this population.
It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE). In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.
For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.
|Marianna Shershneva, MD, PhD||Accreditation Specialist||No relevant relationships with ineligible companies to disclose||No|
|Andrea Moosreiner, MPH, RD, CD||Author||No relevant relationships with ineligible companies to disclose||No|
|Michele Polfuss, PhD, RN, CPNP-AC/PC||Author||No relevant relationships with ineligible companies to disclose||No|
|Bethany Forseth, PhD, MS||Author||No relevant relationships with ineligible companies to disclose||No|
|Magnolia Larson, DO||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Mary L. Ehlenbach, MD||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Puneet Arora, MD||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Roberta Pawlak, PhD, RN, NEA-BC||Reviewer||No relevant relationships with ineligible companies to disclose||No|
|Sarina Schrager, MD||Editor||No relevant relationships with ineligible companies to disclose||No|
*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.
The ACCME does not consider providers of clinical services directly to patients to be ineligible companies.
|In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.|
Credit Designation Statements
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC)
The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 ANCC contact hour.
Continuing Education Units
The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC Contact Hours
- 1.00 University of Wisconsin–Madison Continuing Education Hours
- 1.00 Approved for AMA PRA Category 1 Credit™
Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly.
Free, current version of Adobe Acrobat Reader or other .pdf reader.